Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,669 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
As XRP stabilizes near the $1 mark, analysts split on whether the chart signals an imminent breakout or a renewed pul...
Bitcoin is hovering around the $60,000 level as macro risks and liquidity shifts weigh on traders. This piece breaks ...
Bitcoin slips as Hormuz tensions push oil higher and yields up, renewing inflation fears. The move highlights bitcoin...
As inflation cools and the Fed’s stance evolves, rate-sensitiveDividend Stocks like Realty Income can become powerful...
Memory stocks look risky on the surface, yet the fundamentals are unusually strong. This article decodes what history...
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
As DNOW readies its 2025 earnings narrative, investors should focus on backlog, free cash flow, and guidance. This gu...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
BitMine Immersion Technologies expanded its ETH treasury by 50,928 ETH, sparking a roughly 9% rise in BMNR shares and...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...